Hypothesis-driven medication discovery for the treatment of psychostimulant addiction. [electronic resource]
Producer: 20090813Description: 303-27 p. digitalISSN:- 1874-4745
- Animals
- Brain -- drug effects
- Cannabinoid Receptor Modulators -- metabolism
- Central Nervous System Stimulants
- Cocaine-Related Disorders -- diagnosis
- Dopamine -- metabolism
- Dopamine Agonists -- adverse effects
- Dopamine Antagonists -- adverse effects
- Drug Evaluation, Preclinical
- Excitatory Amino Acid Agonists -- adverse effects
- GABA Agonists -- adverse effects
- GABA Uptake Inhibitors
- Glutamic Acid -- metabolism
- Humans
- Narcotic Antagonists -- adverse effects
- Receptors, AMPA -- antagonists & inhibitors
- Receptors, N-Methyl-D-Aspartate -- antagonists & inhibitors
- Serotonin Antagonists -- adverse effects
- Serotonin Receptor Agonists
- Substance-Related Disorders -- diagnosis
- Treatment Outcome
- Vesicular Monoamine Transport Proteins -- antagonists & inhibitors
- gamma-Aminobutyric Acid -- metabolism
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Intramural; Review
There are no comments on this title.
Log in to your account to post a comment.